Virtual FDA/Duke-Margolis Public Meeting: Innovation in Quantitative Medicine Summit
Click here to register
On September 1, 2026, the FDA Quantitative Medicine Center of Excellence, in collaboration with the Duke-Margolis Institute for Health Policy, will host the “Innovation in Quantitative Medicine Summit” virtual public meeting. This one-day meeting aims to inform the establishment of the Quantitative Medicine Innovation Network, a cross-sector collaboration to advance the science and regulatory application of quantitative medicine with the goal of fundamentally transforming drug development and clinical care.
For more information and to register, visit the meeting website.
The Office of Clinical Pharmacology (OCP) offers two e-mail subscription services, Clinical Pharmacology Corner and Quantitative Medicine, including Model-Informed Drug Development. These emails are a free service from FDA to provide occasional updates from OCP regarding newly approved therapies, new regulatory and scholarly publications, upcoming events, and other items of interest. Subscribe today or click the button below and select Clinical Pharmacology Corner and Quantitative Medicine, including Model-Informed Drug Development under DRUGS.
We always welcome your thoughts regarding the format, content, and utility of our communications. Comments may be sent via email to ocp@fda.hhs.gov.
This communication was prepared by the Office of Clinical Pharmacology, Office of Translational Sciences, CDER, FDA.
|
